No approved treatment in US; Phase 3 redesign underway at Lykos
MDMA-assisted therapy is a treatment model combining MDMA administration with structured psychotherapy for PTSD. Typically 2-3 sessions of 8 hours each. Developed primarily by MAPS over 30+ years. Rejected by the FDA in August 2024.